A phase II study of concurrent chemoradiotherapy combined with a weekly paclitaxel and 5-fluorouracil regimen to treat patients with advanced oesophageal carcinoma
Crossref DOI link: https://doi.org/10.1186/s13014-017-0785-0
Published Online: 2017-03-07
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xia, Yi
Li, Yun-hai
Chen, Yun
Zhang, Jun-hua
Liu, Qi
Deng, Jia-ying
Ai, Ta-shan
Zhu, Han-ting
Fan, Jian-hong
Badakhshi, Harun
Zhao, Kuai-le
Funding for this research was provided by:
National Natural Science Foundation of China Research (Grant No. 21172043 and No.21441010)